To dissect the impact of inflammatory stromal components WP2 investigates the role of tumour-associated macrophages in coculture models in-vitro and elucidates the impact of macrophage-inhibition in genetically engineered mouse models. The role of immunomodulatory cells is investigated in a humanized immune-reconstituted (HIR) mouse model, hosting both the xenotransplanted bone-marrow derived immune system and the adenocarcinoma of the same pancreatic cancer patient. Therapeutic monoclonal antibodies and DNA vaccines are developed towards a selection of tumour antigens validated in human and engineered mouse models.

WP lead:

Philipps-Universität Marburg, Germany (UNIMAR)

WP members:

The University of Liverpool, United Kingdom (ULIV) per Participant
Fundación Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO)
University of Verona, Italy (UNIVR)
Ernst-Moritz-Arndt-Universität Greifswald, Germany (EMAU-G)
Technische Universität München, Klinikum rechts der Isar, Germany (TUM-MED)
Bayer Schering Healthcare, Germany (BSP)
Fondazione Centro San Raffaele del Monte Tabor, Italy (CeRMS-UniTO)
NatiMab Therapeuticals SRL, Italy (NatiMab)

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.